Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

HUMA

Humacyte (HUMA)

Humacyte Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:HUMA
일자시간출처헤드라인심볼기업
2024/03/0906:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
2024/03/0420:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2024/03/0106:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HUMAHumacyte Inc
2024/03/0106:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2024/02/0922:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2023/12/1306:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1306:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/12/1222:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2023/11/1006:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
2023/11/1006:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2023/10/1105:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/10/1105:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/09/1605:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
2023/09/1605:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/09/1605:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/09/1220:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2023/09/1209:03Dow Jones NewsStocks to Watch: Oracle, Acelyrin, HumacyteNASDAQ:HUMAHumacyte Inc
2023/08/2207:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/08/2207:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/08/2207:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
2023/08/1805:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAHumacyte Inc
2023/08/1421:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
2023/08/1420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
2023/08/0102:28Dow Jones NewsHumacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 TrialNASDAQ:HUMAHumacyte Inc
2023/07/2621:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
 검색 관련기사 보기:NASDAQ:HUMA